Viemed Healthcare Inc
TSX:VMD
Intrinsic Value
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. [ Read More ]
The intrinsic value of one
VMD
stock under the Base Case scenario is
9.89
CAD.
Compared to the current market price of 10.45 CAD,
Viemed Healthcare Inc
is
Overvalued by 5%.
Viemed Healthcare Inc's market capitalization is 402.3m CAD.
VMD stock price is 10.45 CAD.
VMD stock (9.89 CAD) is 5% less than its price (10.45 CAD).
VMD has upside potential of 78% compared to the average analyst price target.
Open Wall St Estimates
VMD has positive Net Income for the last twelve months.
VMD's ROE (Return on Equity) for the past 12 months is positive and is equal to 9%.
VMD has positive Operating Income for the last twelve months.
VMD's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
VMD's short-term assets (36m USD) exceed its short-term liabilties (32m USD).
VMD's Revenue has grown by an exceptional 27% over the past 12 months.
VMD has positive three-year average ROIC (Return on Invested Capital): 16%. The company is efficient at using invested capital to generate operating income.
VMD's Revenue has been growing by 14% per year for the last 3 years.
VMD has positive Free Cash Flow for the last twelve months.
VMD has positive three-year average ROE (Return on Equity): 18%. The company is efficient at transforming stockholders' equity into net income.
VMD has negative Net Debt. This means that the company has more cash and short-term investments (10m USD) than debt (8m USD).
VMD's ROE (Return on Equity) has significantly decreased in the last 3 years from 44% to 9%.
VMD's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 37% to 8%.
VMD has positive Gross Profit for the last twelve months.
VMD's long-term assets (149m USD) exceed its long-term liabilties (41m USD).
VMD's D/E (Debt to Equity) is very low and is equal to 0.08.
VMD's Altman Z-Score is very high and is equal to 7.28.
VMD earns more than enough operating income (13m USD) to safely cover interest payments on its debt (540k USD).
Valuation Backtest
Viemed Healthcare Inc
Run backtest to discover the historical profit from buying and selling
VMD
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Viemed Healthcare Inc
Balance Sheet Decomposition
Viemed Healthcare Inc
| Current Assets | 35.9m |
| Cash & Short-Term Investments | 10.1m |
| Receivables | 17.9m |
| Other Current Assets | 7.9m |
| Non-Current Assets | 113.5m |
| Long-Term Investments | 3.9m |
| PP&E | 74.4m |
| Intangibles | 30.4m |
| Other Non-Current Assets | 4.8m |
| Current Liabilities | 31.6m |
| Accounts Payable | 9.3m |
| Accrued Liabilities | 13.7m |
| Other Current Liabilities | 8.6m |
| Non-Current Liabilities | 9m |
| Long-Term Debt | 8.3m |
| Other Non-Current Liabilities | 700k |
Earnings Waterfall
Viemed Healthcare Inc
|
Revenue
|
169.8m
USD
|
|
Cost of Revenue
|
-66.2m
USD
|
|
Gross Profit
|
103.6m
USD
|
|
Operating Expenses
|
-90.4m
USD
|
|
Operating Income
|
13.1m
USD
|
|
Other Expenses
|
-3.9m
USD
|
|
Net Income
|
9.2m
USD
|
Free Cash Flow Analysis
Viemed Healthcare Inc
VMD Profitability Score
Profitability Due Diligence
Viemed Healthcare Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Viemed Healthcare Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
VMD Solvency Score
Solvency Due Diligence
Viemed Healthcare Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
Viemed Healthcare Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VMD Price Targets Summary
Viemed Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
VMD
is 18.63 CAD
.
Shareholder Return
VMD Price
Viemed Healthcare Inc
| Average Annual Return | -1.65% |
| Standard Deviation of Annual Returns | 26.35% |
| Max Drawdown | -65% |
| Market Capitalization | 402.3m CAD |
| Shares Outstanding | 38 489 000 |
| Percentage of Shares Shorted | 0.33% |
Company Profile
Viemed Healthcare Inc
Country
Industry
Market Cap
Dividend Yield
Description
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana. The company went IPO on 2017-12-22. Viemed is focused on providing in-home treatment with clinical practitioners and providing therapy, and counseling to patients in their homes using technology. Viemed’s products and services include Home Medical Equipment and In-home sleep testing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. The company provides home medical equipment through a range of service programs, including respiratory disease management, Neuromuscular care, Oxygen therapy and Sleep apnea. In-home sleep testing provides in home sleep apnea testing services, which is an alternative to the traditional sleep lab testing environment.
Contact
IPO
Employees
Officers
The intrinsic value of one
VMD
stock under the Base Case scenario is
9.89
CAD.
Compared to the current market price of 10.45 CAD,
Viemed Healthcare Inc
is
Overvalued by 5%.
You don't have any saved screeners yet
